Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05521997
Title Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma

cervical cancer

Therapies

Cisplatin + Telaglenastat

Cisplatin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.